Sputum proteomics of CF, BE and COPD with or without NTM infections
R. Hull (Sheffield, United Kingdom), J. Huang (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), H. Ellis (London, United Kingdom), B. Cookson (London, United Kingdom), M. Moffatt (London, United Kingdom), M. Loebinger (London, United Kingdom), J. Chalmers (Dundee, United Kingdom)
Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Hull (Sheffield, United Kingdom), J. Huang (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), H. Ellis (London, United Kingdom), B. Cookson (London, United Kingdom), M. Moffatt (London, United Kingdom), M. Loebinger (London, United Kingdom), J. Chalmers (Dundee, United Kingdom). Sputum proteomics of CF, BE and COPD with or without NTM infections. 3091
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: